(Q35847323)

10 August 2017

1 reference

title

From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension (English)

1 reference

10 August 2017

1 reference

Ernesto L Schiffrin

1

1 reference

PubMed ID

15277186

10 August 2017

Rhian M Touyz

series ordinal

2

1 reference

10 August 2017

1 August 2004

1 reference

American Journal of Physiology Heart and Circulatory Physiology

10 August 2017

1 reference

10 August 2017

287

1 reference

10 August 2017

2

1 reference

10 August 2017

H435-46

1 reference

Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation--contraction coupling in isolated resistance vessels from essential hypertensives.

10 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Inward remodeling follows chronic vasoconstriction in isolated resistance arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Is C-reactive protein an independent risk factor for essential hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Localization of vascular resistance changes during hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Vascular inflammation and the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

A systematic review of predictors of maintenance of normotension after withdrawal of antihypertensive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

RhoA/Rho-kinase, vascular changes, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Endothelial activation by angiotensin II through NFkappaB and p38 pathways: Involvement of NFkappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Assembly of the neutrophil respiratory burst oxidase: a direct interaction between p67PHOX and cytochrome b558 II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Apoptosis in cardiovascular remodeling--effect of medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Collagen I and III mRNA gene expression and cell growth potential of skin fibroblasts in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Angiotensin II induces catecholamine release by direct ganglionic excitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Endothelium-dependent relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Apoptosis in the muscular arteries from young spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Structural and functional analysis of small arteries from young spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Candesartan Reduces Oxidative Stress and Inflammation in Patients with Essential Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Free radicals in the physiological control of cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Angiotensin II type 1 receptor participates in extracellular matrix production in the late stage of remodeling after vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Impaired vasodilator function in hypertension: the role of alterations in receptor-G protein coupling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Oxidant signals and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Growth factors and mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

v-Src's hold over actin and cell adhesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Molecular mechanisms of the exaggerated growth of vascular smooth muscle cells in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Insulin sensitivity and the risk of incident hypertension: insights from the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

GIT1 Mediates Src-dependent Activation of Phospholipase Cγ by Angiotensin II and Epidermal Growth Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Small artery structure in hypertension. Dual processes of remodeling and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II: from large arteries to the microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Recent progress in angiotensin II type 2 receptor research in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Growth characteristics, angiotensin II generation, and microarray-determined gene expression in vascular smooth muscle cells from young spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Intrinsic and extrinsic uncoupling of oxidative phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Meeting the challenges of the new K/DOQI guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Histology of subcutaneous small arteries from patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Altered mitogen-activated protein kinase activation in vascular smooth muscle cells from spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Interactions between NO and cAMP in the regulation of vascular tone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Transforming growth factor-beta inhibition of proteasomal activity: a potential mechanism of growth arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Reduction of the soluble cyclic GMP vasorelaxing system in the vascular wall of stroke-prone spontaneously hypertensive rats: effect of the alpha1 -receptor blocker doxazosin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Soluble cell adhesion molecules in hypertensive concentric left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

NOX family NADPH oxidases: do they have built-in proton channels?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Sepiapterin decreases vasorelaxation in nitric oxide synthase inhibition-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Preliminary characterisation of the promoter of the human p22(phox) gene: identification of a new polymorphism associated with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Inhibition of renin-angiotensin system ameliorates endothelial dysfunction associated with aging in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a three-dimensional disector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

The regulation of human vascular smooth muscle extracellular matrix protein production by alpha- and beta-adrenoceptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Correlation of endothelial function in large and small arteries in human essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Adrenergic mechanisms and remodeling of subcutaneous small resistance arteries in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Early changes in proteoglycans production by resistance arteries smooth muscle cells of hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Relations between cardiac and vascular structure in patients with primary and secondary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Prognostic significance of small-artery structure in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Time course of apoptosis in small resistance arteries of spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Aortic smooth muscle cell phenotypic modulation and fibrillar collagen deposition in angiotensin II-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Angiotensin II-mediated signal transduction pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Importance of tyrosine phosphorylation in angiotensin II type 1 receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Reactivity of small blood vessels in hypertension: relation with structural changes. State of the art lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

State-of-the-Art lecture. Role of endothelin-1 in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

C-reactive protein and the risk of developing hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Structural vascular changes in hypertension: role of angiotensin II, dietary sodium supplementation, blood pressure, and time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Cardiovascular protection and blood pressure reduction: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Angiotensin and its AT2 receptor: new insights into an old system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

The inflammatory aspect of the microcirculation in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Cell transformation by the superoxide-generating oxidase Mox1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Eicosapentaenoic acid protects endothelial cells against anoikis through restoration of cFLIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Reactive oxygen species in the vasculature: molecular and cellular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Molecular recognitions in the MAP kinase cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Extracellular matrix biology: a new frontier in linking the pathology and therapy of hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Hypertensive vascular disease and inflammation: mechanical and humoral mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Angiotensin II modulates nitric oxide-induced cardiac fibroblast apoptosis by activation of AKT/PKB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Redox signaling and the MAP kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Contribution of endothelin-1 to renal activator protein-1 activation and macrophage infiltration in aldosterone-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

p38 Map kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Role of calcium influx and intracellular calcium stores in angiotensin II-mediated calcium hyper-responsiveness in smooth muscle from spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Role of c-Src in the regulation of vascular contraction and Ca2+ signaling by angiotensin II in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Role of p22phox in angiotensin II and platelet-derived growth factor AA induced activator protein 1 activation in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Spironolactone improves angiotensin-induced vascular changes and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Mechanical strain increases endothelin-1 gene expression via protein kinase C pathway in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Reactive oxygen species: roles in blood pressure and kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Angiotensin II responses of vascular smooth muscle cells from hypertensive rats: enhancement at the level of p42 and p44 mitogen activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Structural factors increase blood pressure through the interaction of resistance vessel geometry with neurohumoral and local factors: estimates in rabbits with renal cellophane-wrap hypertension with intact effectors and during neurohumoral blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

Sustained production of H(2)O(2) activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-kappa B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00262.2004

10.1152/AJPHEART.00262.2004

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15277186